Literature DB >> 21607932

Changes in objective vault and effect on vision outcomes after implantable Collamer lens implantation: 1-year follow-up.

Gai-Ping Du1, Yi-Fei Huang, Li-Qiang Wang, Da-Jiang Wang, Hui-Ling Guo, Ji-Feng Yu, Yu-Bo Gong, Jing Song, Hou-Bing Huang.   

Abstract

PURPOSE: To investigate the changes in vault and the effect on visual outcomes 1 year after implantable Collamer lens (ICL) implantation.
METHODS: In this retrospective study, 127 eyes of 66 patients undergoing ICL implantation were examined both before and up to 1 year after the surgery. The examination contents included white-to-white (WTW) diameter, central vault of the ICL (distance between posterior surface of ICL and anterior surface of crystalline lens), refractive error, and wavefront high-order aberration (HOA). All statistical analyses were performed using SPSS 13.0 software.
RESULTS: A significant decrease in vault was noted up to 1 month, after which the value stabilized (p=0.001). The moderate vault decreased significantly after the first 3 months postsurgery (paired-samples t test, p<0.05). Low vault showed a tendency to increase and high vault showed a tendency to decrease, but not significantly, over time. There was no statistically significant correlation between the amount of vault and the refractive error (Pearson correlation coefficient R=0.111, p=0.473) and there was a statistically significant correlation between the vault and HOAs (R=0.304, p=0.024).
CONCLUSIONS: Implantable Collamer lens vault over the crystalline lens had the tendency toward a slight decrease with time and did not significantly affect the vision outcome 1 year after surgery.

Entities:  

Mesh:

Year:  2012        PMID: 21607932     DOI: 10.5301/EJO.2011.8359

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  8 in total

Review 1.  Analysis of perioperative problems related to intraocular Implantable Collamer Lens (ICL) implantation.

Authors:  Hao Zhang; Rui Gong; Xiaolan Zhang; Yingping Deng
Journal:  Int Ophthalmol       Date:  2022-06-22       Impact factor: 2.029

Review 2.  Meta-analysis and review: effectiveness, safety, and central port design of the intraocular collamer lens.

Authors:  Mark Packer
Journal:  Clin Ophthalmol       Date:  2016-06-09

3.  Comparison of early changes in and factors affecting vault following posterior chamber phakic Implantable Collamer Lens implantation without and with a central hole (ICL V4 and ICL V4c).

Authors:  Xun Chen; Huamao Miao; Rajeev Krishnan Naidu; Xiaoying Wang; Xingtao Zhou
Journal:  BMC Ophthalmol       Date:  2016-09-07       Impact factor: 2.209

4.  Refractive outcomes of implantation of an implantable phakic copolymer lens with peripheral holes in the intraocular posterior chamber in moderate to high myopia patients: a single-surgeon series.

Authors:  Praveen Subudhi; Sweta Patro; Zahiruddin Khan; B Nageswar Rao Subudhi; Silla Sitaram
Journal:  Clin Ophthalmol       Date:  2019-09-23

5.  Effect of pupil size on posterior chamber phakic intraocular lens vault measurements.

Authors:  Arjun Srirampur; Veerendranath Pesala; Tarannum Mansoori; Aruna Kumari Gadde; Pravalika Kola
Journal:  Indian J Ophthalmol       Date:  2021-09       Impact factor: 1.848

6.  Comparison of white-to-white measurements using four devices and their determination of ICL sizing.

Authors:  Robert Edward T Ang; Edward Kenneth F Reyes; Fernando Amado J Ayuyao; Maria Isabel N Umali; Emerson M Cruz
Journal:  Eye Vis (Lond)       Date:  2022-10-02

7.  Clinical observations of EVO-ICL implantation and changes in corneal astigmatism using a modified technique.

Authors:  Ying Wang; Ruibo Yang; Yue Huang; Chen Zhang; Hui Liu; Zhe Jia; Shaozhen Zhao
Journal:  BMC Ophthalmol       Date:  2022-09-23       Impact factor: 2.086

8.  Analysis of intraocular positions of posterior implantable collamer lens by full-scale ultrasound biomicroscopy.

Authors:  Xi Zhang; Xun Chen; Xiaoying Wang; Fei Yuan; Xingtao Zhou
Journal:  BMC Ophthalmol       Date:  2018-05-09       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.